ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Other Long-Term Assets
ESSA Pharma Inc
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Other Long-Term Assets
$257.3k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Other Long-Term Assets
$11m
|
CAGR 3-Years
32%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Long-Term Assets
$396k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Long-Term Assets
$4.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
117%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Long-Term Assets
$1.5m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
30%
|
CAGR 10-Years
31%
|
|
Spectral Medical Inc
TSX:EDT
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ESSA Pharma Inc's Other Long-Term Assets?
Other Long-Term Assets
257.3k
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Other Long-Term Assets amounts to 257.3k USD.
What is ESSA Pharma Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
5%
Over the last year, the Other Long-Term Assets growth was -14%. The average annual Other Long-Term Assets growth rates for ESSA Pharma Inc have been -5% over the past three years , 5% over the past five years .